[Federal Register: November 28, 2003 (Volume 68, Number 229)]
[Notices]               
[Page 66829-66834]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr28no03-67]                         

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
Cooperative Agreement for Research on the Association Between 
Exposure to Media Violence and Youth Violence

    Announcement Type: New.
    Funding Opportunity Number: 04060.
    Catalog of Federal Domestic Assistance Number: 93.136.
    Key Dates:
    Letter of Intent Deadline: December 29, 2003.
    Application Deadline: February 17, 2004.

I. Funding Opportunity Description

    Authority: This program is authorized under section 301 (a) [42 
U.S.C. 241(a)] of the Public Health Service Act and section 391 
(a)[42 U.S.C. 280b (a)] of the Public Service Health Act, as 
amended.

    Purpose: The purpose of the program is to conduct methodologically 
sound research on how media violence affects youth violent behavior. 
This program addresses the ``Healthy People 2010'' focus area of Injury 
and Violence Prevention.
    Measurable outcomes of the program will be in alignment with the 
following performance goal for the National Center for Injury 
Prevention and Control (NCIPC): Conduct a targeted program of research 
to reduce injury-related death and disability.

[[Page 66830]]

Research Objectives

    There has been a longstanding concern about the consequences of 
youths' exposure to violence in the media, with particular concern 
about the effects of such exposure on violent behavior. Recent studies 
have documented the profusion of different types of media in United 
States homes \1-3\ and the widespread presence of violence in these 
media outlets.\4,5\ The emergence and proliferation of new media (e.g., 
video games, music videos, Internet sites, and DVD) have increased 
opportunities for children and youth to be exposed to violence. Despite 
the fact that there has been extensive research on this subject, at 
least three key gaps remain in our understanding of the relationship 
between youth exposure to media violence and violent behavior. First, 
more information is needed about the effects of different types of new 
media and their content on violent behavior. Second, while substantial 
research has described associations between exposure to violent media 
on attitudes and measures of aggression, less is known about the extent 
to which exposure to violent media is associated with risk for more 
serious forms of violence, including victimization and perpetration 
resulting in injury. Third, a relatively small subset of youth may be 
particularly susceptible to the effects of exposure to violent media. 
Additional research is needed to understand the individual and 
contextual factors that influence the association between exposure to 
violent media and risk for violence.
    The purpose of the current program announcement is to conduct 
methodologically sound research on how media influences youth 
susceptibility to violence. Project proposals should be designed to: 
(1) Examine the association between exposure to violent media and 
serious violent behavior, including victimization and perpetration 
resulting in injury; (2) include an assessment of the specific aspects 
of media (e.g., type and content) that are likely to contribute to risk 
for violence; and (3) identify individual and contextual factors that 
mediate or moderate the association between exposure to violent media 
and serious violent behavior, with particular attention to the 
potential moderating effects of gender and prior exposure to real-life 
violence.

Funding Priority

    Priority will be given to research proposals that include a focus 
on (a) new forms of media; (b) serious forms of violence, including 
victimization and perpetration resulting in injury; and (c) describing 
the individual and contextual factors that influence the association 
between exposure to violent media and risk for violence.

Activities

    Awardee activities for this program are as follows:
    1. In collaboration with CDC finalize the research design and 
methodology, data collection measures, analyses, and dissemination of 
the study results through publication and presentations.
    2. In collaboration with CDC finalize a research protocol for 
Institutional Review Board (IRB) review by all cooperating institutions 
participating in the research project.
    3. Conduct one reverse site visit to meet with CDC staff in Atlanta 
on an annual basis.
    4. Complete all required reports as specified under ``Reporting 
Requirements'' of this program announcement.
    In a cooperative agreement, CDC staff is substantially involved in 
the program activities, above and beyond routine grant monitoring.
    CDC activities for this program are as follows:
    1. Serve as co-investigator and provide scientific oversight. CDC 
will actively collaborate with project staff on decision-analyses, 
interpretation of findings, and dissemination of the study results 
through involvement in the production of publications and 
presentations.
    2. Assist in finalizing the research protocol for IRB review by all 
cooperating institutions participating in the research project. The CDC 
IRB will review and approve the protocol initially and on at least an 
annual basis until the research project is finished.
    3. Facilitate regular communication between CDC and the grantee to 
include, but not limited to site visits, conference calls, meetings, 
etc.

II. Award Information

    Type of Award: Cooperative Agreement. CDC involvement in this 
program is listed in the Activities Section above.
    Fiscal Year Funds: 2004.
    Approximate Total Funding: $600,000.
    Approximate Number of Awards: Two.
    Approximate Average Award: $300,000.
    Floor of Award Range: None.
    Ceiling of Award Range: $300,000.
    Anticipated Award Date: August 2, 2004.
    Budget Period Length: 12 months.
    Project Period Length: Three years.
    Throughout the project period, CDC's commitment to continuation 
awards will be conditioned on the availability of funds, evidence of 
satisfactory progress by the recipient (as documented in required 
reports), and the determination that continued funding is in the best 
interest of the Federal Government.

III. Eligibility Information

    1. Eligible applicants: Applications may be submitted by public and 
private nonprofit organizations and by governments and their agencies, 
such as:

[sbull] Public nonprofit organizations
[sbull] Private nonprofit organizations
[sbull] Small, minority, women-owned businesses
[sbull] Universities
[sbull] Colleges
[sbull] Research institutions
[sbull] Hospitals
[sbull] Community-based organizations
[sbull] Faith-based organizations
[sbull] Federally recognized Indian tribal governments
[sbull] Indian tribes
[sbull] Indian tribal organizations
[sbull] State and local governments or their bona fide agents (this 
includes the District of Columbia, the Commonwealth of Puerto Rico, the 
Virgin Islands, the Commonwealth of Mariana Islands, American Samoa, 
Guam, the Federated States of Micronesia, the Republic of the Marshall 
Islands, and the Republic of Palau)
[sbull] Political subdivisions of States (in consultation with States)

    A Bona Fide Agent is an agency/organization identified by the state 
as eligible to submit an application under the state eligibility in 
lieu of a state application. If you are applying as a bona fide agent 
of a state or local government, you must provide a letter from the 
state as documentation of your status. Place this documentation behind 
the first page of your application form.
    2. Cost Sharing or Matching: Matching funds are not required for 
this program.
    3. Other Eligibility Requirements:
    Applications that are incomplete or non-responsive to the below 
requirements will be returned to the applicant without further 
consideration. You will be notified that your application did not meet 
submission requirements.
    The following are applicant requirements:
    1. A principal investigator who has conducted research, published 
the

[[Page 66831]]

findings in peer-reviewed journals, and has specific authority and 
responsibility to carry out the proposed project.
    2. Demonstrated experience on the applicant's project team in 
conducting, evaluating, and publishing violence prevention research in 
peer-reviewed journals.
    3. Effective and well-defined working relationships within the 
performing organization and with outside entities, which will ensure 
implementation of the proposed activities.
    4. The overall match between the applicant's proposed research 
objectives and the program priorities as described under the heading, 
``Funding Priority''.
    5. The requested funding amount should not be greater than the 
ceiling of the award amount.
    6. Principal investigators (PI's) are encouraged to submit only one 
proposal in response to this program announcement. With few exceptions 
(e.g., research issues needing immediate public health attention), only 
one application per PI will be funded under this announcement.

    Note: Title 2 of the United States Code section 1611 states that 
an organization described in section 501(c)(4) of the Internal 
Revenue Code that engages in lobbying activities is not eligible to 
receive Federal funds constituting an award, grant, or loan.

IV. Application and Submission Information

1. Address to Request Application Package

    To apply for this funding opportunity, use application Form PHS 398 
(OMB Number 0925-0001 rev. 5/2001). Forms and instructions are 
available in an interactive format on the CDC Web site, at the 
following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm.
    Forms and instructions are also available in an interactive format 
on the National Institutes of Health (NIH) web site at the following 
Internet address: http://grants.nih.gov/grants/funding/phs398/phs398.html.
 If you do not have access to the Internet, or if you have 
difficulty accessing forms on-line, you may contact the CDC Procurement 
and Grants Office Technical Information Management Section (PGO-TIM) 
staff at 770-488-2700. Application forms can be mailed to you.

2. Content and Form of Application Submission Letter of Intent (LOI)

    CDC requests that you send a LOI if you intend to apply for this 
program. Although the LOI is not required, not binding, and does not 
enter into the review of your subsequent application, the LOI will be 
used to gauge the level of interest in this program, and to allow CDC 
to plan the application review. Your LOI must be written in the 
following format:

[sbull] Maximum number of pages: Two
[sbull] Font size: 12-point unreduced
[sbull] Paper size: 8.5 by 11 inches
[sbull] Single Spaced
[sbull] Page margin size: One inch
[sbull] Printed only on one side of page
[sbull] Written in English, avoid jargon
    Your LOI must contain the following information:
[sbull] Descriptive title of the proposed research
[sbull] Name, address, E-mail address, and telephone number of the 
Principal Investigator
[sbull] Names of other key personnel
[sbull] Participating institutions
[sbull] Number and title of this Program Announcement (PA)

    Application: Follow the PHS 398 application instructions for 
content and formatting of your application. See all attachments of this 
announcement as it is posted on the CDC Web site for guidance on how to 
complete Form 398 for this Program Announcement. The Program 
Announcement Title and number must appear in the application. For 
further assistance with the PHS 398 application form, contact GrantsInfo, Telephone (301) 435-0714, email: GrantsInfo@nih.gov.
    You must include a research plan with your application. The 
research plan should be no more than 25 pages (8.5'' x 11'' in size), 
single-spaced, printed on one side only, with one-inch margins on all 
sides, and unreduced 12-point font.
    Your application will be evaluated on the criteria listed under 
Section V. Application Review Information, so it is important to follow 
them, as well as the Research Objectives and the Administrative and 
National Policy Requirements (AR's), in laying out your research plan. 
Your research plan should address activities to be conducted over the 
entire project period.
    The research plan should consist of the following information:
    1. Abstract. Provide a one page brief description of proposed 
research activities and project outcomes. It is important to include an 
abstract that reflects the project's focus, because the abstract will 
be used to help determine the responsiveness of the application.
    2. Goals and Objectives. Describe the goals and objectives the 
proposed research is designed to achieve in the short and long term. 
Specific research questions and hypotheses should also be included. In 
addition, the research plan should include an outline of a three-year 
plan with timeline.
    3. Program Participants. Describe the study population for the 
proposed research and how participants will be selected (i.e., sampling 
strategy). In addition, the research plan should provide evidence that 
the recipient (or a collaborating partner) has access to the study 
population, and that the participation by the study population will be 
adequate to test hypotheses.
    4. Methods. Describe the proposed study design; methods, and 
analysis plan to test the proposed study hypotheses.
    5. Project Management. Provide evidence of the expertise, capacity, 
and existing staff necessary to successfully conduct the research. Each 
existing or proposed position for the project should be described by 
job title, function, general duties, level of effort and allocation of 
time. Management operation principles, structure, and organization 
should also be noted.
    6. Collaborative Efforts. List and describe the current and 
proposed collaborations with government, health, or youth agencies, 
community- or faith-based organizations, minority organizations, and 
other researchers. Include letters of support and memoranda of 
understanding that specify the nature of past, present, and proposed 
collaborations, and the products/services/activities that will be 
provided by and to the applicant.
    7. Data Sharing and release: Describe plans for the sharing and 
release of data (See AR-25 for additional information).
    8. Project Budget. Provide a detailed budget for each activity 
undertaken, with accompanying justification of all operating expenses 
that is consistent with the stated objectives and planned activities of 
the project. This announcement does not use the modular budget format. 
The budget should include at least one trip per year to CDC for program 
related meetings.
    You are required to have a Dun and Bradstreet Data Universal 
Numbering System (DUNS) number to apply for a grant or cooperative 
agreement from the Federal government. Your DUNS number must be entered 
in item 11 of the face page of the PHS 398 application form. The DUNS 
number is a nine-digit identification number, which uniquely identifies 
business entities. Obtaining a DUNS number is easy and there is no 
charge. To obtain a DUNS number, access http://www.dunandbradstreet.com 
or call 1-866-705-5711. For more information, see the CDC Web site at: 
http://www.cdc.gov/od/pgo/funding/pubcommt.htm.

[[Page 66832]]

3. Submission Dates and Times

    LOI Deadline Date: December 29, 2003.
    Application Deadline Date: February 17, 2004.
    Explanation of Deadlines: Applications must be received in the CDC 
Procurement and Grants Office by 4 p.m. Eastern Time on the deadline 
date. If you send your application by the United States Postal Service 
or commercial delivery services, you must ensure that the carrier will 
be able to guarantee delivery of the application by the closing date 
and time. If an application is received after closing due to (1) 
carrier error, when the carrier accepted the package with a guarantee 
for delivery by the closing date and time, or (2) significant weather 
delays or natural disasters, CDC will upon receipt of proper 
documentation, consider the application as having been received by the 
deadline.
    This announcement is the definitive guide on application submission 
address and deadline. It supersedes information provided in the 
application instructions. If your application does not meet the 
deadline above, it will not be eligible for review, and will be 
discarded. You will be notified that you did not meet the submission 
requirements.
    CDC will not notify you upon receipt of your application. If you 
have a question about the receipt of your application, first contact 
your courier. If you still have any questions, contact the PGO-TIM 
staff at: 770-488-2700. Before calling, please wait two to three days 
after the application deadline. This will allow time for applications 
to be processed and logged.
    4. Intergovernmental Review: Executive Order 12372 does not apply 
to this program.
    5. Funding Restrictions: Restrictions, which must be taken into 
account while writing your budget, are as follows: None
    If you are requesting indirect costs in your budget, you must 
include a copy of your indirect cost rate agreement. If your indirect 
cost rate is a provisional rate, the agreement must be less than 12 
months of age.
    Awards will not allow reimbursement of pre-award costs.

6. Other Submission Requirements

    LOI Submission Address: Submit your LOI by express mail, delivery 
service, fax, or E-mail to: Robin Forbes, National Center for Injury 
Prevention and Control, Centers for Disease Control and Prevention, 
4770 Buford Hwy, NE., Mailstop K-62, Atlanta, GA 30341, Fax: 770-488-1662. Telephone: 770-488-4037. Email: CIPERT@cdc.gov.
    Application Submission Address: Submit the signed original and five 
copies of your application by mail or express delivery to: Technical 
Information Management--PA 04060, Procurement and Grants 
Office, Centers for Disease Control and Prevention, 2920 Brandywine 
Road, Atlanta, GA 30341.
    Applications may not be submitted electronically at this time.

V. Application Review Information

    1. Criteria: You are required to provide measures of effectiveness 
that will demonstrate the accomplishment of the various identified 
objectives of the cooperative agreement. Measures of effectiveness must 
relate to the performance goals stated in the ``Purpose'' section of 
this announcement. Measures must be objective and quantitative, and 
must measure the intended outcome. These measures of effectiveness must 
be submitted with the application and will be an element of evaluation.
    The goals of CDC-supported research are to advance the 
understanding of biological systems, improve the control and prevention 
of disease, and enhance health. In the written comments, reviewers will 
be asked to evaluate the application in order to judge the likelihood 
that the proposed research will have a substantial impact on the 
pursuit of these goals. The scientific review group will address and 
consider each of the following criteria in assigning the application's 
overall score, weighting them as appropriate for each application.
    The application does not need to be strong in all categories to be 
judged likely to have major scientific impact and thus serve a high 
priority score. For example, an investigator may propose to carry out 
important work that by its nature is not innovative, but is essential 
to move a field forward.
    The criteria are as follows:
    Significance: Does this study address an important problem? If the 
aims of the application are achieved, how will scientific knowledge be 
advanced? What will be the effect of these studies on the concepts or 
methods that drive this field?
    Approach: Are the conceptual framework, design, methods, and 
analyses adequately developed, scientifically rigorous, well-
integrated, and appropriate to the aims of the project? Does the 
applicant acknowledge potential problem areas and consider alternative 
tactics?
    Innovation: Does the project employ novel concepts, approaches or 
methods? Are the aims original and innovative? Does the project 
challenge existing paradigms or develop new methodologies or 
technologies?
    Investigator: Is the investigator appropriately trained and well 
suited to carry out this work? Is the work proposed appropriate to the 
experience level of the principal investigator and other researchers 
(if any)?
    Environment: Does the scientific environment in which the work will 
be done contribute to the probability of success? Does the proposed 
research take advantage of unique features of the scientific 
environment or employ useful collaborative arrangements? Is there 
evidence of institutional support?
    Additional Review Criteria:
    Protection of Human Subjects from Research Risks: Does the 
application adequately address the requirements of Title 45 CFR Part 46 
for the protection of human subjects? This will not be scored, however, 
an application can be disapproved if the research risks are 
sufficiently serious and protection against risks is so inadequate as 
to make the entire application unacceptable.
    Inclusion of Women and Minorities in Research: Does the application 
adequately address the CDC Policy requirements regarding the inclusion 
of women, ethnic, and racial groups in the proposed research? This 
includes: (1) The proposed plan for the inclusion of both sexes and 
racial and ethnic minority populations for appropriate representation; 
(2) The proposed justification when representation is limited or 
absent; (3) A statement as to whether the design of the study is 
adequate to measure differences when warranted; and (4) A statement as 
to whether the plans for recruitment and outreach for study 
participants include the process of establishing partnerships with 
community(ies) and recognition of mutual benefits.
    Inclusion of Children as Participants in Research Involving Human 
Subjects:
     The NIH maintains a policy that children (i.e., individuals under 
the age of 21) must be included in all human subjects research, 
conducted or supported by the NIH, unless there are scientific and 
ethical reasons not to include them. This policy applies to all initial 
(Type 1) applications submitted for receipt dates after October 1, 
1998.
    All investigators proposing research involving human subjects 
should read the ``NIH Policy and Guidelines'' on the inclusion of 
children as participants in research involving human subjects that is 
available at: http://grants.nih.gov/grants/funding/children/children.htm
.

[[Page 66833]]

    Budget: The reasonableness of the proposed budget and the requested 
period of support in relation to the proposed research.
    2. Review and Selection Process: Applications will be reviewed for 
completeness by the Procurement and Grants Office (PGO) and for 
responsiveness by the NCIPC. Incomplete applications and applications 
that are non-responsive will not advance through the review process. 
Applicants will be notified that their application did not meet 
submission requirements.
    Applications that are complete and responsive to the PA will be 
subjected to a preliminary evaluation (streamline review) by a peer 
review committee, the Initial Review Group (IRG) convened by NCIPC, to 
determine if the application is of sufficient technical and scientific 
merit to warrant further review by the IRG. CDC will withdraw from 
further consideration applications judged to be noncompetitive and 
promptly notify the principal investigator or program director and the 
official signing for the applicant organization. Those applications 
judged to be competitive will be further evaluated by a dual review 
process.
    1. The primary review will be a peer review conducted by the IRG. 
All applications will be reviewed for scientific merit in accordance 
with the review criteria listed above. Applications will be assigned a 
priority score based on the National Institutes of Health (NIH) scoring 
system of 100-500 points.
    2. The secondary review will be conducted by the Science and 
Program Review Subcommittee (SPRS) of NCIPC's Advisory Committee for 
Injury Prevention and Control (ACIPC). The ACIPC Federal agency experts 
will be invited to attend the secondary review, and will receive 
modified briefing books (i.e., abstracts, strengths and weaknesses from 
summary statements, and project officer's briefing materials). ACIPC 
Federal agency experts will be encouraged to participate in 
deliberations when applications address overlapping areas of research 
interest, so that unwarranted duplication in federally-funded research 
can be avoided and special subject area expertise can be shared. The 
NCIPC Division Associate Directors for Science (ADS) or their designees 
will attend the secondary review in a similar capacity as the ACIPC 
Federal agency experts to assure that research priorities of the 
announcement are understood and to provide background regarding current 
research activities. Only SPRS members will vote on funding 
recommendations, and their recommendations will be carried to the 
entire ACIPC for voting by the ACIPC members in closed session. If any 
further review is needed by the ACIPC, regarding the recommendations of 
the SPRS, the factors considered will be the same as those considered 
by the SPRS.
    The committee's responsibility is to develop funding 
recommendations for the NCIPC Director based on the results of the 
primary review, the relevance and balance of proposed research relative 
to the NCIPC programs and priorities, and to assure that unwarranted 
duplication of federally-funded research does not occur. The secondary 
review committee has the latitude to recommend to the NCIPC Director, 
to reach over better-ranked proposals in order to assure maximal impact 
and balance of proposed research. The factors to be considered will 
include:
    a. The results of the primary review including the application's 
priority score as the primary factor in the selection process.
    b. The relevance and balance of proposed research relative to the 
NCIPC programs and priorities.
    c. The significance of the proposed activities in relation to the 
priorities and objectives stated in ``Healthy People 2010,'' the 
Institute of Medicine report, ``Reducing the Burden of Injury,'' and 
the ``CDC Injury Research Agenda.''
    All awards will be determined by the Director of the NCIPC based on 
priority scores assigned to applications by the IRG, recommendations by 
the secondary review committee, e.g., NCIPC's Advisory Committee for 
Injury Prevention and Control (ACIPC), consultation with NCIPC senior 
staff, and the availability of funds.

VI. Award Administration Information

    1. Award Notices: Successful applicants will receive a Notice of 
Grant Award (NGA) from the CDC Procurement and Grants Office. The NGA 
shall be the only binding, authorizing document between the recipient 
and CDC. The NGA will be signed by an authorized Grants Management 
Officer, and mailed to the recipient fiscal officer identified in the 
application.
    2. Administrative and National Policy Requirements:
45 CFR Part 74 and 92
    For more information on the Code of Federal Regulations, see the 
National Archives and Records Administration at the following Internet 
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
    The following additional requirements apply to this project:

AR-1 Human Subjects Requirements
AR-2 Requirements for Inclusion of Women and racial and Ethnic 
Minorities in Research
AR-9 Paperwork Reduction Act Requirements Projects that involve the 
collection of information from ten or more persons and that are funded 
by cooperative agreements will be subject to review and approval by the 
Office of Management and Budget (OMB).
AR-10 Smoke-Free Workplace Requirements
AR-11 Healthy People 2010
AR-12 Lobbying Restrictions
AR-13 Prohibition on Use of CDC Funds for Certain Gun Control 
Activities
AR-21 Small, Minority, Women-Owned Businesses
AR-22 Research Integrity
AR-23 States and Faith-Based Organizations
AR-24 Health Insurance Portability and Accountability Requirements
AR-25 Release and Sharing of Data
    Starting with the December 1, 2003 receipt date, all NCIPC funded 
investigators seeking more than $250,000 in total costs in a single 
year are expected to include a plan describing how the final research 
data will be shared/released or explain why data sharing is not 
possible. Details on data sharing/release, including the timeliness and 
name of the project data steward, should be included in a brief 
paragraph immediately following the Research Plan Section of the PHS 
398 form. References to data sharing/release may also be appropriate in 
other sections of the application (e.g. background and significance, 
human subjects requirements, etc.) The content of the data sharing/
release plan will vary, depending on the data being collected and how 
the investigator is planning to share the data. The data sharing/
release plan will not count towards the application page limit and will 
not factor into the determination scientific merit or priority scores. 
Investigators should seek guidance from their institutions, on issues 
related to institutional policies, local IRB rules, as well as local, 
state and Federal laws and regulations, including the Privacy Rule.
    Further detail on the requirements for addressing data sharing in 
applications for NCIPC funding may be obtained by contacting NCIPC 
program staff or visiting the NCIPC Internet Web site: at http://www.cdc.gov/ncipc/osp/sharing_policy.htm
.
    Additional information on these requirements can be found on the 
CDC

[[Page 66834]]

Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm
.
    3. Reporting: You must provide the CDC with original and two copies 
of the following reports:
    1. Interim progress report (PHS 2590, OMB Number 0925-0001, rev. 5/
2001) no less than 90 days before the end of the budget period. The 
progress report will serve as your non-competing continuation 
application, and must contain the following elements:
    a. Current Budget Period Activities Objectives
    b. Current Budget Period Financial Progress.
    c. New Budget Period Program Proposed Activity Objectives.
    d. Detailed Line-Item Budget and Justification.
    e. Additional Requested Information.
    2. Financial status report, no more than 90 days after the end of 
the budget period.
    3. Final financial status and performance reports, no more than 90 
days after the end of the project period.

VII. Agency Contacts

    For general questions about this announcement, contact: Technical 
Information Management Section, Procurement and Grants Office, Centers 
for Disease Control and Prevention, 2920 Brandywine Road, Atlanta, GA 
30341-4146, Telephone: (770) 488-2700.
    For questions about scientific/research program technical issues 
contact, Marci Feldman, M.S., Project Officer, Division of Violence 
Prevention, National Center for Injury Prevention and Control, Centers 
for Disease Control and Prevention, 4770 Buford Highway, NE MS K-60, 
Atlanta, GA 30341, Telephone: (770) 488-4478. FAX: (770) 488-4349. Email: MFeldman@cdc.gov.
    For questions about peer review issues, contact, Gwen Cattledge, 
Scientific Review Administrator, National Center for Injury Prevention 
and Control, Centers for Disease Control and Prevention, 4770 Buford 
Hwy, NE, Mailstop K-02, Atlanta, GA 30341, Telephone: 770-488-1430. Email: gxc8@cdc.gov.
    For budget assistance, contact: James Masone, Contracts Specialist, 
Procurement and Grants Office, Centers for Disease Control and 
Prevention, 2920 Brandywine Road, Atlanta, GA 30341-4146, Telephone: 770-488-2736. FAX: 770-488-2671. Email: zft2@cdc.gov.

VIII. Other Information

    References:
    1. National Center for Injury Prevention and Control. CDC Injury 
Research Agenda. Atlanta, GA: Centers for Disease Control and 

new millennium. Menlo Park, CA: Henry J. Kaiser Family Foundation, 
1999.
    3. Woodward EH. Media in the home 2000: The fourth annual survey of 
parents and children (Survey Series No. 7). Philadelphia, PA: The 
Annenberg Public Policy Center of the University of Pennsylvania, 1998.
    4. Wilson BJ, Kunkel D, Linz D, Potter J, Donnerstein E, Smith SL, 
Blumenthal E, Gray T. Violence in television programming overall: 
University of California, Santa Barbara study. In Seawall M. (Ed.), 
National television violence study (Vol. 1, pp. 3-184). Thousand Oaks, 
CA: Sage Publications, 1997.
    Wilson BJ, Kunkel D, Linz D, Potter J, Donnerstein E, Smith SL, 
Blumenthal E, Berry M. Violence in television programming overall: 
University of California, Santa Barbara study. In Seawall M. (Ed.), 
National television violence study (Vol. 2, pp. 3-204). Thousand Oaks, 
CA: Sage Publications, 1998.

    Dated: November 20, 2003.
Edward Schultz,
Acting Director, Procurement and Grants Office, Centers for Disease 
Control and Prevention.
[FR Doc. 03-29632 Filed 11-26-03; 8:45 am]

BILLING CODE 4163-18-P